Triplet repeat disorders: Discussion of molecular mechanisms

Cellular and Molecular Life Sciences

Volumn 55, Issue 11, 1999, Pages 1432-1447

  Timchenko, L T ^a   Caskey, C T ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Fragile X syndrome; Friedreich's ataxia; Molecular pathogenesis; Myotonic dystrophy; Polyglutamine disorders

Indexed keywords

CALCIUM; CALCIUM CHANNEL; CYTOSINE; GUANINE; HOMEODOMAIN PROTEIN; IRON; MUTANT PROTEIN; POLYGLUTAMIC ACID; RNA; RNA BINDING PROTEIN; TRINUCLEOTIDE; URACIL;

ANIMAL MODEL; APOPTOSIS; BRAIN DISEASE; BRAIN NERVE CELL; CELL DEATH; CODON; FRAGILE X SYNDROME; FRIEDREICH ATAXIA; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; HUMAN; IRON TRANSPORT; MOLECULAR GENETICS; MOUSE; MYOTONIC DYSTROPHY; NONHUMAN; PROTEIN FOLDING; REVIEW; RNA PROCESSING; TRINUCLEOTIDE REPEAT; X CHROMOSOME LINKAGE;

EID: 0033618846     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050383     Document Type: Review

References (116)

1. Wells R. D. (1996) Molecular basis of genetic instability of triplet repeats. J. Biol. Chem. 271: 2875-2878
2. Paulson H. L. and Fischbeck K. M. (1996) Trinucleotide repeats in neurogenetic disorders. Ann. Rev. Neurosci. 19: 79-107
3. Reddy P. S. and Housman D. E. (1997) The complex pathology of trinucleotide repeats. Curr. Opin. Cell Biol. 9: 364-372
4. Robitaille Y., Lopes-Cendes I., Becher M., Rouleau G. and Clark A. W. (1997) The neuropathology of CAG repeat diseases: review and update of genetic and molecular features. Brain Pathol. 7: 901-926
5. Harper P. S. (1995) Myotonic dystrophy and other autosomal muscular dystrophies. In: The Molecular and Molecular Bases of Inherited Disease, pp. 4227-4251, Scriver C. R., Beaudet A. L., Sly W. S. and Valle D. (eds), McGraw-Hill, New York
6. Hoogeveen A. T. and Oostra B. A. (1997) The fragile X syndrome. J. Inher. Metab. Dis. 20: 139-151
7. Durr A., Cossee M., Agid Y., Campuzano V., Mignard C., Penet C. et al. (1996) Clinical and genetic abnormalities in patients with Friedreich's ataxia. N. Engl. J. Med. 335: 1169-1175
8. Kremer E. J., Pritchard M., Lynch M., Yu S., Holman K., Baker E. et al. (1991) Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CGG)n. Science 252: 1711-1714
9. Verkerk A. J., Pieretti M., Sutcliffe J. S., Fu Y.-H., Kuhl D. P. A., Pizzuti A. et al. (1991) Identification of a gene (FMR-I) containing a CGG repeat coincident with a break-point cluster region exhibiting length variation in fragile X syndrome. Cell 65: 905-914
10. Fu Y.-H., Kuhl D. P., Pizzuti A., Pieretti M., Sutcliffe J. S., Richards S. et al. (1991) Variation of the CGG repeat at the Fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67: 1047-1058
11. Aslanidis C., Jansen G., Amemiya C., Shutler G., Mahadevan M., Tsilfidis C. et al. (1992) Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 355: 548-551
12. Brook J. D., McCurrach M. E., Harley H. G., Buckler A. J., Church D., Aburatani H. et al. (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of the transcript encoding a protein kinase family member. Cell 68: 799-808
13. Buxton J., Shelbourne P., Davies J., Jones C., Van Tongeren T., Aslanidis C. et al. (1992) Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355: 547-548
14. Fu Y.-H., Pizzuti A., Fenwick R. G., King G., Rajnarayan S., Dunne P. W. et al. (1992) An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255: 1256-1258
15. Harley H. G., Brook J. D., Rundle S. A., Crow S., Reardon W., Buckler A. J. et al. (1992) Expansion of an unstable DNA region phenotypic variations in myotonic dystrophy. Nature 355: 545-546
16. Mahadevan M. S., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., Jansen G. et al. (1992) Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255: 1253-1255
17. Campuzano V., Montermini L., Molto M. D., Pianese L., Cossee M., Cavalcanti F. et al. (1996) Friedrich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271: 1423-1427
18. Bell M. V., Hirst M. C., Nakahori Y., MacKinnon R. N., Roche A., Flint T. J. et al. (1991) Physical mapping across the fragile-X: hypermethylation and clinical expression of the fragile-X syndrome. Cell 64: 861-866
19. Pieretti M., Zhang F. P., Fu Y.-H., Warren S. T., Oostra B. A., Caskey C. T. et al. (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66: 817-822
20. The Dutch-Belgian Fragile X Consortium (1994) Fmrl knockout mice: a model to study fragile X mental retardation. Cell 78: 23-833
21. Siomi H., Siomi M. C., Nussbaum R. L. and Dreyfuss G. (1993) The protein product of the fragile X gene, FMR1, syndrome has characteristics of an RNA-binding protein. Cell 74: 291-298
22. Siomi H., Chol M., Siomi M. C., Nussbaum R. L. and Dreyfuss G. (1994) Essential role of KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77: 33-39
23. Ashley C. T., Wilkinson K. D., Reines D. and Warren S. T. (1993) FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262: 563-566
24. Devys D., Lutz Y., Rouyer N., Bellocq J.-P. and Mandel J.-L. (1993) The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nature Genet. 4: 335-340
25. Khandjian E. W., Corbin F., Woerly S. and Rousseau F. (1996) The fragile X mental retardation protein is associated with ribosomes. Nature Genet. 12: 91-93
26. Eberhart D. E., Malter H. E., Feng Y. and Warren S. T. (1996) The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum. Mol. Genet. 5: 1083-1091
27. Zhang Y., Oconnor J. P., Siomi M. C., Srinivasan S., Dutra A., Nussbaum R. L. et al. (1995) The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J. 14: 5358-5366
28. Fu Y.-H., Friedman D. L., Richards S., Pearlman J. A., Gibbs R. A., Pizzuti A. et al. (1993) Decreased expression of myotonin protein kinase mRNA and protein in adult form of myotonic dystrophy. Science 260: 235-238
29. Timchenko L. T., Monckton D. G. and Caskey C. T. (1995) Myotonic dystrophy: an unstable repeat in a protein kinase gene. Sem. Cell. Biol. 6: 13-19
30. Sabourin L. A., Mahadevan M. S., Narang M., Lee D. S. C., Surh L. C. and Korneluk R. G. (1993) Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene. Nature Genet. 4: 233-238
31. Wang Y.-H., Amirhaeri S., Kang S., Wells R. D. and Griffith J. D. (1994) Preferential nucleosome assembly at DNA triplet repeats from the myotonic dystrophy gene. Science 265: 669-671
32. Steinbach P., Glaser D., Vogel W., Wolf M. and Schwemmle S. (1998) The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat. Am. J. Hum. Genet. 62: 278-285
33. Shaw D. J., Chaudhary S., Rundle S. A., Crow S., Brook J. D., Harper P. S. et al. (1993) A study of DNA methylation in myotonic dystrophy. J. Med. Genet. 30: 189-192
34. Krahe R., Ashizawa T., Abbruzzese C., Roeder E., Carango P., Giacanelli M. et al. (1995) Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics 28: 1-14
35. Wang J., Pegoraro E., Menegazzo E., Gennarelli M., Hoop R. C., Angelini C. et al. (1995) Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum. Mol. Genet. 4: 599-606
36. Hamshere M. G., Newman E. E., Alwazzan M., Athwal B. S. and Brook D. J. (1997) Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes. Proc. Natl. Acad. Sci. USA 94: 7394-7399
37. Davis B. M., McCurrach M. E., Taneja K. L., Singer R. H. and Housman D. F. (1997) Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. USA 94: 7388-7393
38. Taneja K. L., McCurrach M., Schalling M., Housman D. and Singer R. H. (1995) Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol. 128: 995-1002
39. Reddy S., Smith D. B. J., Rich M. M., Leferovich J. M., Reily P., Davis B. M. et al. (1996) Mice lacking the myotonic dystrophy protein kinase develop n late onset progressive myopathy. Nature Genet. 13: 325-335
40. Jansen G., Groenen P. J. T. A., Bacher D., Jap P. H. K., Coerwinkel M., Oerlemans F. et al. (1996) Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nature Genet. 13: 316-324
41. Ordway J. M. and Detloff P. J. (1996) In vitro synthesis and cloning of long CAG repeats. Biotechniques 21: 609-612
42. Monckton D. G., Coolbaugh M. I., Ashizawa K. T., Siciliano M. J. and Caskey C. T. (1997) Hypermutable myotonic dystrophy CTG repeats in transgenic mice. Nature Genet. 15: 193-196
43. Gourdon G., Radvany F., Lia A.-S., Duros C., Blanche M., Abitbol M. et al. (1997) Moderate intergenerational and somatic instability of a 55-CTG repeat in transgenic mice. Nature Genet. 15: 190-192
44. Boucher C. A., King S. K., Carey N., Krahe R., Winchester C. L., Rahman S. et al. (1995) A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat. Hum. Mol. Genet. 4: 1919-1925
45. Tapscott S. J., Klesert T. R., Widrow R. J., Stoger R. and Laird C. D. (1998) Fragile-X syndrome and myotonic dystrophy: parallels and paradoxes. Curr. Opin. Genet. Dev. 8: 245-253
46. Klesert T. R., Otten A. D., Bird T. D. and Tapscott S. J. (1997) Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nature Genet. 16: 402-406
47. Thornton C. A., Wymer J. P., Simmons Z., McClain C. and Moxley R. T. III (1997) Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nature Genet. 16: 407-409
48. Morrone A., Pegoraro E., Angelinin C., Zammarchi E., Marconi G. and Hoffman E. P. (1997) RNA metabolism in myotonic dystrophy: patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance. J. Clin. Invest. 99: 1691-1698
49. Timchenko L. T., Miller J. W., Timchenko N. A., DeVore D. R., Datar K. V., Lin L. et al. (1996) Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 24: 4407-4414
50. Caskey C. T., Swanson M. S. and Timchenko L. T. (1996) Myotonic dystrophy: discussion of molecular mechanism. Cold Spring Harbor Symp. Quant. Biol. 61: 607-614
51. Timchenko L. T., Timchenko N. A., Caskey C. T. and Roberts R. (1996) Novel proteins with binding specificity for DNA CTG and RNA CUG repeats: implications for myotonic dystrophy. Hum. Mol. Genet. 5: 115-121
52. Roberts R., Timchenko N. A., Miller J. W., Reddy S., Caskey C. T., Swanson M. S. et al. (1997) Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonic protein kinase knockout mice. Proc. Natl. Acad. Sci. USA 94: 13221-13226
53. Timchenko L. T., Lu X., Roberts R. and Timchenko N. A. (1998) Myotonic dystrophy: gain of function of RNA (CUG) triplet repeat binding proteins. Am. J. Hum. Genet. Suppl. 63 (Abstr. 32)
54. Philips A. V., Timchenko L. T. and Cooper T. A. (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280: 737-741
55. Descombes P. and Schibler U. (1991) A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated form the same mRNA. Cell 67: 569-579
56. Marian A. J. and Roberts R. (1995) Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 92: 1336-1347
57. Lu X., Timchenko N. A. and Timchenko L. T. (1999) Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG triplet repeats expanded in myotonic dystrophy. Hum. Mol. Genet. 8: 53-60
58. Bhagwati S., Ghatpande A. and Leung B. (1996) Identification of two nuclear proteins which bind to RNA CUG repeats: significance for myotonic dystrophy. Biochem. Biophys. Res. Commun. 228: 55-62
59. Sabourin L. A., Tamai K., Narang M. A. and Korneluk R. G. (1997) Overexpression of 3′-untranslated region of the myotonic dystrophy kinase cDNA inhibits differentiation in vitro. J. Biol. Chem. 272: 29635-29636
60. Mahadevan M. S., Amack J. D. and Paguio A. P. (1998) A cell culture model of the myotonic dystrophy (DM) mutation. Am. J. Hum. Genet. Suppl. 63 (Abstr. 33)
61. 3Hl cells induces the skeletal muscle phenotype. J. Biol. Chem. 271: 548-552
62. Timchenko L. T., Nastainczyk W., Schneider T., Patel B., Hofmann F. and Caskey C. T. (1995) Full-length myotonin protein kinase (72 kDa) displays serine kinase activity. Proc. Natl. Acad. Sci. USA 92: 5366-5370
63. 2+ homeostasis in skeletal muscle cells. J. Clin. Invest. 100: 1440-1447
64. Mounsey J. P., Xu P., John J. E. III, Horne L. T., Gilbert J., Roses A. D. et al. (1995) Modulation of skeletal muscle sodium channels by human myotonin protein kinase. J. Clin. Invest. 95: 2379-2384
65. Fu Y.-H. (1996) Identification of a novel protein, DMAHP, which interacts with the myotonic dystrophy protein kinase and shows strong homology to DI snRNP. Genetica 97: 117-125
66. Rymond B. C. (1993) Convergent transcripts of the yeast PRP38-SMDI locus encode two essential splicing factors, including the DI core polypeptide of small nuclear ribonucleoprotein particles. Proc. Natl. Acad. Sci. USA 90: 848-852
67. Suzuki A., Sugiyama Y., Hayashi Y., Nyu-I. N., Yoshida M., Nonaka I. et al. (1998) MKBP. A novel member of the small heat shock protein family binds and activates the myotonic dystrophy protein kinase. J. Cell Biol. 140: 1113-1124
68. van der Ven P. F. M., Jansen G., van Kuppevelt T. H. M. S. M., Perryman M. B., Lupa M., Dunne P. W. et al. (1993) Myotonic dystrophy kinase is a component of neuromuscular junctions. Hum. Mol. Genet. 2: 1889-1894
69. Ishizaki T., Maekawa M., Fujisawa K., Okawa K., Iwamatsu A., Fujita A. et al. (1996) The small GTP-binding protein Rho binds to and activates a 160 kDa ser/thr protein kinase homologous to myotonic dystrophy kinase. EMBO J. 15: 1885-1893
70. 2+ sensitization of smooth muscle. Proc. Natl. Acad. Sci. USA 93: 1340-1345
71. Kimura K., Ito M., Amano M., Chihara K., Fukata Y., Nakafuku M. et al. (1996) Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273: 245-248
72. Wissman A., Ingles J., McGhee J. D. and Mains P. E. (1997) Caenorhabditis elegans LET-502 is related to Rho-binding kinases and human myotonic dystrophy kinase and interacts genetically with a homolog of the regulatory subunit of smooth muscle myosin phosphatase to affect cell shape. Genes Dev. 11: 409-422
73. Carvajal J. J., Pook M. A., dos Santos M., Doudney K., Hillermann R., Minogue S. et al. (1996) The Friedreich's ataxia gene encodes a novel phosphatidylinositol-4 phosphate 5-kinase. Nature Genet. 14: 157-162
74. Cossee M., Campuzano V., Koutnikova H., Fishbeck K., Mandel J.-L., Koenig M. et al. (1997) Frataxin fracas. Nature Genet. 15: 337-338
75. Koutnikova H., Campuzano V., Foury F., Dolle P., Cazzalini O. and Koenig M. (1997) Studies of human, mouse and yeast homologues indicated a mitochondrial function of frataxin. Nature Genet. 16: 345-351
76. Babcock M., de Silva D., Oaks R., Davis-Kaplan S., Jiralerspong S., Montermini L. et al. (1997) Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276: 1709-1712
77. Wilson R. B. and Roof D. M. (1997) Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue. Nature Genet. 16: 352-357
78. Cedarbaum J. M. and Blass J. P. (1986) Mitochondrial dysfunction and spinocerebellar degeneration. Neurochem. Pathol. 4: 43-63
79. Gibson T. J., Koonin E. V., Musco G., Pastore A. and Bork P. (1996) Friedreich's ataxia protein: evidence for mitochondrial dysfunction. Trends Neurosci. 19: 465-468
80. Wallace D. C., Shoffner J. M., Trounce I., Brown M. D., Ballinger S. W., Corral-Debrinski M. et al. (1995) Mitochondrial DNA mutations in human degenerative diseases and aging. Biochem. Biophys. Acta 1271: 141-151
81. Lamarche J. B., Shapcott D., Cote M. and Lemieux B. (1991) Cardiac iron deposits in Friedreich's ataxia. In: Handbook of Cerebellar Diseases. pp. 453-457, Lechtenberg R. (ed.), Marcel Dekker, New York
82. Foury F. and Cazzalini O. (1997) Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria. FEBS Lett. 411: 373-377
83. Kaplan J. and O'Halloran T. V. (1996) Iron metabolism in eucaryotes: Mars and Venus at it again. Science 271: 1510-1512
84. Kispal G., Csere P., Guiard B. and Lill R. (1997) The ABC transporter Atmlp is required for mitochondrial iron homeostasis. FEBS Lett. 418: 346-350
85. La Spada A. R., Wilson E. M., Lubahn D. B., Harding A. E. and Fischbeck K. H. (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature (London) 352: 77-79
86. Zhuchenko O., Bailey J., Bonnen P., Ashizawa T., Stockton D. W., Amos C. et al. (1997) Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha IA-voltage-dependent calcium channel. Nature Genet. 15: 62-69
87. Burke J. R., Enghild J. J., Martin M. E., Jou Y.-S., Myers R. M., Roses A. D. et al. (1996) Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med. 2: 347-350
88. Koshy B., Matilla T., Burright E. N., Merry D. E., Fischbeck K. H., Orr H. T. et al. (1996) Spinocerebellar ataxia type-I and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum. Mol. Gen. 5: 1311-1318
89. Xiao-J., Shi-H. L., Sharp A. H., Nucifora F. C., Schilling G., Lanahan A. et al. (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378: 398-402
90. Li X.-J., Sharp A. H., Li S.-H., Dawson T. M., Snyder S. H. et al. (1996) Huntingtin-associated protein (HAP-1): discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase. Proc. Natl. Acad. Sci. USA 93: 4839-4844
91. Bao J., Sharp A. H., Wagster M. V., Becher M., Schilling G., Ross C. A. et al. (1996) Expansion of poluglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc. Natl. Acad. Sci. USA 93: 5037-5042
92. Kalchman M. A., Graham R. K., Xia G., Koide B. H., Hodgson J. G., Graham K. C. et al. (1996) Huntingtin is ubiquitinated and interacts with a specific ubiquitin conjugating enzyme. J. Biol. Chem. 271: 19385-19394
93. Matilla A., Koshy B. T., Cummings C. J., Isobe T., Orr H. T. and Zoghbi H. Y. (1997) The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature 389: 974-978
94. Skinner P. J., Koshy B. T., Cummings C. J., Klement I. A., Helin K., Servadio A. et al. (1997) Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 389: 971-974
95. Burright E. N., Orr H. T. and Clark H. B. (1997) Mouse models of human CAG repeat disorders. Brain Pathol. 7: 965-977
96. Goldberg Y. P., Kalchman M. A., Metzler M., Nasir J., Zeisler J., Graham R. et al. (1996) Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript. Hum. Mol. Genet. 5: 177-185
97. Ikeda H., Yamaguchi M., Sugai S., Aze Y., Narumiya S. and Kakizuka A. (1996) Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genet. 13: 196-202
98. Cummings C. J., Mancini M. A., Antalffy B., DeFranco D. B., Orr H. T. and Zoghbi H. Y. (1998) Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nature Genet. 19: 148-154
99. Davies S. W., Turmaine M., Cozens B. A., DiFigilia M., Sharp A. H., Ross C. A. et al. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90: 537-548
100. Martindale D., Hackam A., Wieczorek A., Ellerby L., Wellington C., McCutcheon K. et al. (1998) Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nature Genet. 18: 150-154
101. Paulson H. L., Das S. S., Crino P. B., Perez M. K., Patel S. C., Gotsdiner D. et al. (1997) Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19: 333-344
102. Igarashi S., Koide R., Shimohata T., Yamada M., Hayashi Y., Takano H. et al. (1998) Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cell expressing truncated DRPLA protein with expanded polyglutamine stretch. Nature Genet. 18: 111-117
103. Prusiner S. B. and Hsiao K. K. (1994) Human prion diseases. Ann. Neurol. 35: 385-395
104. Klement I. A., Skinner P. J., Kaytor M. D., Yi H., Hersch S. M., Clark H. B. et al. (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95: 41-53
105. Saudou F., Finkbeiner S., Devys D. and Greenberg M. E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95: 55-66
106. Thornberry N. A. and Lazebnik Y. (1998) Caspases: enemies within. Science 281: 1312-1316
107. DiFigilia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P. et al. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277: 1991-1993
108. Thornberry N. A., Rano T. A., Peterson E. P., Rasper D. M., Timkey T., Garcia-Calvo M. et al. (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272: 17907-17911
109. Wellington C. L., Ellerby L. M., Hackam A. S., Margolis R. L., Trifiro M. A., Singaraja R. et al. (1998) Caspase cleavage of gene products associated with triplet repeat expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273: 9159-9167
110. Zeitlin S., Liu J.-P., Chapman D. L., Papaioannou V. E. and Efstratiadis A. (1995) Increased apoptosis early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nature Genet. 11: 155-162
111. Duyao M. P., Auerbach A. B., Ryan A., Persichetti F., Barues G. T., McVeil S. M. et al. (1995) Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269: 407-410
112. Nasir J., Floresco S. B., O'Kusky J. R., Diewert V. M., Richman J. M., Zeisler J. et al. (1995) Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81: 811-825
113. Perutz M. F., Johnson T., Suzuki M. and Finch J. T. (1994) Glutamine repeats as polar zippers: their possible role in inherited neuropsychiatric diseases. Proc. Natl. Acad. Sci. USA 91: 5355-5358
114. Green H. (1993) Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism. Cell 74: 955-956
115. Burright E. N., Davidson J. D., Duvick L. A., Koshy B., Zoghbi H. Y. and Orr H. T. (1997) Identification of a self-association region within the SCA1 gene product, ataxin-1. Hum. Mol. Genet. 6: 513-518
116. Kahlem P., Terre C., Green H. and Djian P. (1996) Peptides containing glutamine repeats as substrates for transglutaminase-catalized cross-linking: relevance to diseases of the nervous system. Proc. Natl. Acad. Sci. USA 93: 14580-14585